Avantor Inc
NYSE:AVTR
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Avantor Inc
NYSE:AVTR
|
5.3B USD |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
948.1B USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
177.8B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
138B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
33.5B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.1B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
29.1B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.6B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.6B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Avantor Inc
Glance View
Avantor Inc. is a unique force in the world of life sciences, a field where precision and reliability are as vital as oxygen to human existence. This Pennsylvania-based corporation manages to weave a complex tapestry of innovation and efficiency in its mission to support scientific advancement across the globe. Avantor operates within a diverse landscape, offering a vast array of products that cater to a wide spectrum of industries, including biotechnology, pharmaceutical, healthcare, industrial, and applied materials. At its core, the company functions as a crucial provider of high-purity materials, customized solutions, and highly specialized services that researchers, scientists, and professionals rely on daily to push the boundaries of what's possible. Avantor makes its money through its strategic integration of manufacturing high-quality laboratory and production materials with a comprehensive distribution network. The company boasts a robust catalog of over six million products, including chemicals, reagents, and other essential laboratory supplies. By leveraging its expansive reach and deep-rooted presence in over 30 countries, Avantor efficiently links product innovation with customer needs. Their operations are not merely transactional but are deeply embedded with a service-oriented approach, ensuring that they not only meet the diverse needs of their clients but also continually innovate to help advance scientific breakthroughs. Profitability stems from both the direct sale of products and long-term service agreements, which foster enduring partnerships and create a strong revenue stream, reinforcing Avantor's stature as a pillar in the life sciences sector.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Avantor Inc is 32.7%, which is below its 3-year median of 33.7%.
Over the last 3 years, Avantor Inc’s Gross Margin has decreased from 34.6% to 32.7%. During this period, it reached a low of 32.7% on Jan 1, 2026 and a high of 34.6% on Dec 31, 2022.